Author: Trüeb, R.M.; Régnier, A.; Caballeroâ€Uribe, N.; Reis Gavazzoni Dias, M.F.; Dutra Rezende, H.
Title: Extraordinary claims without extraordinary evidence: controversy on antiâ€androgen therapy for COVIDâ€19 Cord-id: m9tjvnrm Document date: 2021_4_8
ID: m9tjvnrm
Snippet: We read with much interest McCoy et al's report on 5-alpha-reductase inhibitors associated with reduced frequency of coronavirus disease 2019 (COVID-19) symptoms in males with androgenetic alopecia (AGA).1 Incidentally, a day later, a previously healthy 40-year old male treating his AGA with 1 mg oral finasteride daily since 2 years, reported having suffered from confirmed infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) only two months earlier.
Document: We read with much interest McCoy et al's report on 5-alpha-reductase inhibitors associated with reduced frequency of coronavirus disease 2019 (COVID-19) symptoms in males with androgenetic alopecia (AGA).1 Incidentally, a day later, a previously healthy 40-year old male treating his AGA with 1 mg oral finasteride daily since 2 years, reported having suffered from confirmed infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) only two months earlier.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date